BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25052047)

  • 1. Development and evaluation of an algorithm to identify users of Prolia(®) during the early postmarketing period using health insurance claims data.
    Hoffman V; Xue F; Gardstein B; Skerry K; Critchlow CW; Enger C
    Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):993-8. PubMed ID: 25052047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of off-label use of denosumab 60 mg injection during the early postmarketing period using health insurance claims data.
    Hoffman V; Xue F; Gardstein B; Skerry K; Critchlow CW; Enger C
    Osteoporos Int; 2016 Apr; 27(4):1653-1658. PubMed ID: 26558380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia® (denosumab) for the treatment of postmenopausal osteoporosis.
    Xue F; Ma H; Stehman-Breen C; Haller C; Katz L; Wagman RB; Critchlow CW;
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1107-14. PubMed ID: 23857864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of an algorithm for identifying urinary retention in a cohort of patients with epilepsy in a large US administrative claims database.
    Quinlan SC; Cheng WY; Ishihara L; Irizarry MC; Holick CN; Duh MS
    Pharmacoepidemiol Drug Saf; 2016 Apr; 25(4):413-21. PubMed ID: 26889887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of claims-based diagnostic codes for idiopathic thrombotic thrombocytopenic purpura in a commercially-insured population.
    Wahl PM; Terrell DR; George JN; Rodgers JK; Uhl L; Cataland S; Bohn RL
    Thromb Haemost; 2010 Jun; 103(6):1203-9. PubMed ID: 20352159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for systematic reviews of administrative database studies capturing health outcomes of interest.
    McPheeters ML; Sathe NA; Jerome RN; Carnahan RM
    Vaccine; 2013 Dec; 31 Suppl 10():K2-6. PubMed ID: 24331070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of Canadian health administrative databases in identifying patients with rheumatoid arthritis: a validation study using the medical records of rheumatologists.
    Widdifield J; Bernatsky S; Paterson JM; Tu K; Ng R; Thorne JC; Pope JE; Bombardier C
    Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1582-91. PubMed ID: 23592598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying newly approved medications in Medicare claims data: a case study using tocilizumab.
    Curtis JR; Xie F; Chen R; Chen L; Kilgore ML; Lewis JD; Yun H; Zhang J; Wright NC; Delzell E
    Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1214-21. PubMed ID: 24038595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned.
    Carnahan RM; Moores KG
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():82-9. PubMed ID: 22262596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of an algorithm for the identification of breast cancer deaths in German health insurance claims data: a validation study based on a record linkage with administrative mortality data.
    Langner I; Ohlmeier C; Haug U; Hense HW; Czwikla J; Zeeb H
    BMJ Open; 2019 Jul; 9(7):e026834. PubMed ID: 31350240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based drug-related anaphylaxis in children and adolescents captured by South Carolina Emergency Room Hospital Discharge Database (SCERHDD) (2000-2002).
    West SL; D'Aloisio AA; Ringel-Kulka T; Waller AE; Clayton Bordley W
    Pharmacoepidemiol Drug Saf; 2007 Dec; 16(12):1255-67. PubMed ID: 17918773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population.
    Wahl PM; Rodgers K; Schneeweiss S; Gage BF; Butler J; Wilmer C; Nash M; Esper G; Gitlin N; Osborn N; Short LJ; Bohn RL
    Pharmacoepidemiol Drug Saf; 2010 Jun; 19(6):596-603. PubMed ID: 20140892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Algorithms for identification of Guillain-Barré Syndrome among adolescents in claims databases.
    Funch D; Holick C; Velentgas P; Clifford R; Wahl PM; McMahill-Walraven C; Gladowski P; Platt R; Amato A; Chan KA
    Vaccine; 2013 Apr; 31(16):2075-9. PubMed ID: 23474311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does a claims diagnosis of autism mean a true case?
    Burke JP; Jain A; Yang W; Kelly JP; Kaiser M; Becker L; Lawer L; Newschaffer CJ
    Autism; 2014 Apr; 18(3):321-30. PubMed ID: 23739541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Performance evaluation of hospital claims database for the identification of incident central nervous system tumors compared with a cancer registry in Gironde, France, 2004].
    Coureau G; Baldi I; Savès M; Jaffré A; Barat C; Gruber A; Loiseau H; Kostrzewa A; Servas V; Salamon R; Gilleron V
    Rev Epidemiol Sante Publique; 2012 Aug; 60(4):295-304. PubMed ID: 22704681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corroboration of claims algorithm for second-line costs of metastatic colorectal cancer treatment with targeted agents.
    Dacosta Byfield S; Yu E; Morlock R; Evans D; Teitelbaum A
    J Med Econ; 2013 Aug; 16(8):1071-81. PubMed ID: 23777222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Design and Validation of a New Algorithm to Identify Incident Fractures in Administrative Claims Data.
    Wright NC; Daigle SG; Melton ME; Delzell ES; Balasubramanian A; Curtis JR
    J Bone Miner Res; 2019 Oct; 34(10):1798-1807. PubMed ID: 31170317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of vertebral compression fractures using administrative claims data.
    Curtis JR; Mudano AS; Solomon DH; Xi J; Melton ME; Saag KG
    Med Care; 2009 Jan; 47(1):69-72. PubMed ID: 19106733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Recursive Partitioning to Derive and Validate a Claims-Based Algorithm for Identifying Keratinocyte Carcinoma (Nonmelanoma Skin Cancer).
    Chan AW; Fung K; Tran JM; Kitchen J; Austin PC; Weinstock MA; Rochon PA
    JAMA Dermatol; 2016 Oct; 152(10):1122-1127. PubMed ID: 27533718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of claims-based algorithms for gout flares.
    MacFarlane LA; Liu CC; Solomon DH; Kim SC
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):820-6. PubMed ID: 27230083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.